Mr. Ruben Krupik is a Chairman at Bank Hapoalim BM, a Chief Executive Officer at Arteaga Construction, Inc. and a Member-Executive Director at The Institute for Medical Biomathematics. Mr. Krupik was previously employed as a Chairman by Andromeda Biotech Ltd., a Chairman by Gamida Cell Ltd., a Chief Executive Officer by Clal Biotechnology Industries Ltd., a Chairman by MediWound Ltd., a Non-Executive Chairman by D-Pharm Ltd., a Founder by Avantry Ltd., a Chief Executive Officer by Clal Biotechnology Industries Ltd. (Venture Capital), a Principal by Galil Medical Ltd., a Principal by Given Imaging Ltd., and a Principal by Tadiran Telecommunications Ltd.

He also served on the board at BioCancell Therapeutics, Inc., Recanati Winery Ltd., Anchiano Therapeutics Ltd., Compugen Ltd., CureTech Ltd., Ham-Let (Israel-Canada) Ltd. and Mentor Graphics Development Services (Israel) Ltd.

He received his undergraduate degree from The Hebrew University of Jerusalem and a graduate degree from Tel-Aviv University.